Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate : An Interrupted Time Series Study
-
Abtahi, Shahab (Utrecht University)
;
Pajouheshnia, Romin (Utrecht University) ;
Durán, Carlos E. (University Medical Center Utrecht) ;
Riera-Arnau, Judit (Hospital Universitari Vall d'Hebron) ;
Gamba, Magdalena (Utrecht University) ;
Alsina, Ema (University Medical Center Utrecht) ;
Hoxhaj, Vjola (University Medical Center Utrecht) ;
Andersen, Morten (University of Copenhagen. Department of Drug Design and Pharmacology) ;
Bartolini, Claudia (Agenzia Regionale di Sanità della Toscana) ;
Kristiansen, Sarah Brøgger (University of Copenhagen. Department of Drug Design and Pharmacology) ;
Brown, Jeremy (London School of Hygiene & Tropical Medicine) ;
Hallgreen, Christine Erikstrup (University of Copenhagen. Copenhagen Centre for Regulatory Science) ;
Garcia-Poza, Patricia (Agencia Espanola de Medicamentos y Productos Sanitarios) ;
Gardarsdottir, Helga (UMCU. Department of Clinical Pharmacy) ;
Gini, Rosa (Agenzia Regionale di Sanità della Toscana) ;
Girardi, Anna (Agenzia Regionale di Sanità della Toscana) ;
Holthuis, Emily (PHARMO Institute for Drug Outcomes Research) ;
Huerta, Consuelo (Universidad Complutense de Madrid. Departamento de Salud Pública y Materno-Infantil) ;
Ibáñez, Luisa (Hospital Universitari Vall d'Hebron) ;
Limoncella, Giorgio (Agenzia Regionale di Sanità della Toscana) ;
Martín-Pérez, Mar (Agencia Espanola de Medicamentos y Productos Sanitarios) ;
Paoletti, Olga (Agenzia Regionale di Sanità della Toscana) ;
Roberto, Giuseppe (Agenzia Regionale di Sanità della Toscana) ;
Souverein, Patrick (Utrecht University) ;
Swart, Karin M. A. (PHARMO Institute for Drug Outcomes Research) ;
Wing, Kevin (London School of Hygiene & Tropical Medicine) ;
Sturkenboom, Miriam (University Medical Center Utrecht) ;
Klungel, Olaf (Utrecht University) ;
Universitat Autònoma de Barcelona
visitant ::
identificació
Subscriure's to this discussion. You will then receive all new comments by email.
